País: Armènia
Idioma: anglès
Font: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
cefuroxime (cefuroxime sodium)
GlaxoSmithKline Manufacturing SpA
J01DC02
cefuroxime (cefuroxime sodium)
750mg
powder for solution for injection
glass vial
Prescription
Registered
2019-12-26
SUMMARY OF PRODUCT CHARACTERISTICS _ZINACEF_™ CEFUROXIME SODIUM QUALITATIVE AND QUANTITATIVE COMPOSITION _ZINACEF _Injection contains 250 mg, 750 mg, 1 g and 1.5 g of cefuroxime (as cefuroxime sodium). _ZINACEF MONOVIAL™ _contains 750 mg and 1.5 g of cefuroxime (as cefuroxime sodium). PHARMACEUTICAL FORM Powder for solution for injection (Injection) Powder for solutuon for infusion (_MONOVIAL_) CLINICAL PARTICULARS INDICATIONS _ZINACEF _is a bactericidal cephalosporin antibiotic which is resistant to most beta-lactamases and is active against a wide range of Gram-positive and Gram-negative organisms. It is indicated for the treatment of infections before the infecting organism has been identified or when caused by sensitive bacteria. Susceptibility to _ZINACEF _will vary with geography and time and local susceptibility data should be consulted where available (_see Pharmacological _ _properties, Pharmacodynamics_). Indications include: respiratory tract infections for example, acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and post-operative chest infections ear, nose and throat infections for example, sinusitis, tonsillitis, pharyngitis and otitis media urinary tract infections for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria soft-tissue infections for example, cellulitis, erysipelas and wound infections bone and joint infections for example, osteomyelitis and septic arthritis obstetric and gynaecological infections, pelvic inflammatory diseases gonorrhoea particularly when penicillin is unsuitable other infections including septicaemia, meningitis and peritonitis prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmonary, oesophageal and vascular surgery where there is increased risk from infection. Usually _ZINACEF _will be effective alone, but when appropriate it may be used in combination with an aminoglycoside antibiotic, or in conjunction with metronidazole (orally Llegiu el document complet